NASDAQ · PATN
Pacer Nasdaq International Patent Leaders ETF
$32.94-$0.96 (-2.85%)
Pacer Nasdaq International Patent Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 15.21% below the high.
Loading market information…
NASDAQ · MEDX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Horizon Kinetics Medical ETF’s quoted price sits in the upper half of its reported 52-week range, 0.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Horizon Kinetics Medical ETF’s forward annual dividend is $0.41 per share, paid annual. The forward yield is 1.07% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
THE COMPANY BEHIND THE TICKER
Listed Funds Trust - Horizon Kinetics Medical ETF is an exchange traded fund launched by Listed Funds Trust. The fund is managed by Horizon Kinetics Asset Management LLC. The fund invests in public equity markets of global region. It invests in stocks of companies operating across healthcare, healthcare equipment and services, healthcare equipment and supplies, healthcare equipment, medical equipment, surgical and laboratory sterilizers, healthcare providers and services, health care services, medical laboratory services, medical research laboratory services, pharmaceuticals, biotechnology and life science sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against the S&P 500 TR Index. Listed Funds Trust - Horizon Kinetics Medical ETF was formed on September 30, 1999 and is domiciled in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 06:22 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$32.94-$0.96 (-2.85%)
Pacer Nasdaq International Patent Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 15.21% below the high.
$33.19-$0.69 (-2.04%)
Strategas Macro Momentum ETF’s quoted price sits in the upper half of its reported 52-week range, 9.41% below the high.
$45.25-$0.76 (-1.65%)
Franklin Genomic Advancements ETF’s quoted price sits in the upper half of its reported 52-week range, 2.1% below the high.
$26.56-$0.07 (-0.26%)
Principal Real Estate Active Opportunities ETF’s quoted price sits in the upper half of its reported 52-week range, 7.07% below the high.
$29.95-$0.46 (-1.51%)
Argent Focused Small Cap ETF’s quoted price sits in the lower half of its reported 52-week range, 10.22% below the high.
$47.86-$0.25 (-0.52%)
Leuthold Select Industries ETF’s quoted price sits in the upper half of its reported 52-week range, 6.8% below the high.
$36.55-$0.15 (-0.41%)
DoubleLine Fortune 500 Equal Weight ETF’s quoted price sits in the upper half of its reported 52-week range, 7.97% below the high.
$40.00-$0.35 (-0.87%)
VanEck Morningstar Global Wide Moat ETF’s quoted price sits in the lower half of its reported 52-week range, 12.53% below the high.
